Display options
Cite
Wiedemann B, Peter K. Induction of beta-lactamase in Gram-negative bacteria. Diagn Microbiol Infect Dis. 1989;12(4):131S-137Sdoi: 10.1016/0732-8893(89)90125-9.
Wiedemann, B., & Peter, K. (1989). Induction of beta-lactamase in Gram-negative bacteria. Diagnostic microbiology and infectious disease, 12(4), 131S-137S. https://doi.org/10.1016/0732-8893(89)90125-9
Wiedemann, B, and Peter, K. "Induction of beta-lactamase in Gram-negative bacteria." Diagnostic microbiology and infectious disease vol. 12,4 (1989): 131S-137S. doi: https://doi.org/10.1016/0732-8893(89)90125-9
Wiedemann B, Peter K. Induction of beta-lactamase in Gram-negative bacteria. Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4):131S-137S. doi: 10.1016/0732-8893(89)90125-9. PMID: 2686915.
Copy Download .nbib Format: NLM
Share it on
Full text links
Elsevier Science

Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4):131S-137S. doi: 10.1016/0732-8893(89)90125-9.

Induction of beta-lactamase in Gram-negative bacteria.

Diagnostic microbiology and infectious disease

B Wiedemann, K Peter

Affiliations

  1. Pharmazeutische Mikrobiologie, University Bonn, Federal Republic of Germany.

PMID: 2686915 DOI: 10.1016/0732-8893(89)90125-9

Abstract

The induction of beta-lactamase in Gram-negative bacteria in vitro has been established. It is possible to distinguish between high and low beta-lactamase inducers in vitro. This differentiation is clinically irrelevant because induction has little effect on the treatment of a bacterial infection with beta-lactam antibiotics. Regardless of the amount of induced beta-lactamase, the kill kinetics are usually not affected. In mutated cells, the regulatory mechanism is destroyed by inactivation of the relevant genes with respect to their regulatory function, particularly by inactivation of the amp D gene. These mutants overproduce the beta-lactamase constitutively, which results in an enzyme level that significantly exceeds the induced level. The induction process is probably not the cause of clinical failures associated with the use of beta-lactam antibiotics. It is concluded that the selection of resistant mutants with constitutive overproduction of beta-lactamase is the reason for most of these treatment failures.

Similar articles

Substances

MeSH terms

Publication Types

LinkOut - more resources